Maiden Pharma case: CDL finds no violation, calls WHO out for blaming company 'prematurely'

Country's drug controller General of India (DCGI) has written a strongly worded letter to Rogerio Gaspar, Director, Regulation and Prequalification, WHO informing that all control samples of the products have been found to be complying with specifications.